Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

New therapeutic agents for urinary incontinence imparted in recent Takeda patents

Feb. 18, 2008

Silodosin NDA accepted for filing by FDA for benign prostatic hyperplasia

Feb. 13, 2008

Plethora reports preliminary results from PSD-506 incontinence study

Feb. 8, 2008

Positive results reported from Nymox's U.S. study of NX-1207 for BPH

Feb. 7, 2008

New therapeutic agents for genitourinary disorders reported in recent Roche patent

Feb. 5, 2008

Nymox to report results of new phase II study of NX-1207 in BPH

Jan. 21, 2008

Shire launches Fosrenol in Spain, completing launch roll-out in E.U. markets

Jan. 18, 2008

Vasopressin V2 receptor agonists prepared and tested at Kissei

Jan. 17, 2008

Lung and renal improvement with sirolimus in tuberous sclerosis complex and LAM / News in Context

Jan. 14, 2008

Phase III study of oxybutynin topical gel for OAB meets primary and secondary endpoints

Jan. 10, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...